Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Cardiovasc Drugs Ther. 2008 Oct 24;23(1):41–48. doi: 10.1007/s10557-008-6140-9

Fig. 2.

Fig. 2

The potential involvement of leukotrienes in the different stages of the atherosclerosis process eventually leading to cerebral and myocardial ischemia. Abbreviations: SMC smooth muscle cells, MMP matrix metalloproteinase, I/R ischemia and reperfusion